Mullin, Jennifer <br/><br/>
Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.  [electronic resource] 

 -  Vaccine  Mar 2016 
 - 1688-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2016.02.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Viral--immunology<br/>B-Lymphocytes--immunology<br/>Cells, Cultured<br/>Child<br/>Child, Preschool<br/>Cross Reactions<br/>Humans<br/>Immunity, Mucosal<br/>Influenza A Virus, H1N1 Subtype<br/>Influenza A Virus, H3N2 Subtype<br/>Influenza A Virus, H5N1 Subtype<br/>Influenza Vaccines--immunology<br/>Leukocytes, Mononuclear--immunology<br/>Lymphoid Tissue--immunology<br/>Nasopharynx--immunology<br/>Neutralization Tests<br/>Nucleocapsid Proteins<br/>Palatine Tonsil--immunology<br/>RNA-Binding Proteins--immunology<br/>Recombinant Proteins--immunology<br/>T-Lymphocytes--immunology<br/>Vaccinia virus<br/>Viral Core Proteins--immunology<br/>Viral Matrix Proteins--immunology<br/>Young Adult